Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

2016: The year when deal-makers took stock?

2016: The year when deal-makers took stock? Canada for biosimilar versions of Rituxan (rituximab) and Herceptin (trastuzumab). .

Genentech names Anderson new CEO as Ian Clark retires

Genentech names Anderson new CEO as Ian Clark retires Big-selling brands such as breast cancer therapy Herceptin (trastuzumab), Avastin (bevacizumab) for solid tumours and MabThera/Rituxan (rituximab) for non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are

NICE backs Roche’s Perjeta for routine NHS use

NICE backs Roche’s Perjeta for routine NHS use Given in combination with Herceptin (trastuzumab) and docetaxel, Perjeta (pertuzumab) was recommended to treat women with HER2-positive, locally advanced, inflammatory or early-stage breast cancer at high risk of recurrence. ... preparation for surgery

Boehringer says Avastin biosimilar on track as Phase III gets underway

Boehringer says Avastin biosimilar on track as Phase III gets underway Avastin has been on the market since 2004 and along with breast cancer drug Herceptin (trastuzumab) has been the mainstay of Roche's cancer portfolio, bringing in nearly $7bn in sales

Pfizer’s first-in-class breast cancer therapy wins EU licence

Pfizer’s first-in-class breast cancer therapy wins EU licence A number of metastatic breast cancer treatments have been rejected by the UK cost-effectiveness watchdog over the last few years, including GlaxoSmithKline's Tyverb (lapatinib) and Roche's Herceptin (trastuzumab),

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics